Czech National Bank’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.82M | Buy |
12,002
+257
| +2% | +$39K | 0.01% | 488 |
|
|
2025
Q1 | $1.77M | Buy |
11,745
+657
| +6% | +$98.9K | 0.02% | 489 |
|
|
2024
Q4 | $2.05M | Buy |
11,088
+571
| +5% | +$105K | 0.02% | 470 |
|
|
2024
Q3 | $2.07M | Buy |
10,517
+701
| +7% | +$138K | 0.02% | 466 |
|
|
2024
Q2 | $2.03M | Buy |
9,816
+791
| +9% | +$163K | 0.02% | 455 |
|
|
2024
Q1 | $2.45M | Buy |
9,025
+41
| +0.5% | +$11.1K | 0.03% | 427 |
|
|
2023
Q4 | $2.12M | Buy |
8,984
+23
| +0.3% | +$5.44K | 0.03% | 437 |
|
|
2023
Q3 | $1.76M | Buy |
8,961
+2,902
| +48% | +$569K | 0.03% | 446 |
|
|
2023
Q2 | $1.27M | Buy |
6,059
+65
| +1% | +$13.7K | 0.03% | 447 |
|
|
2023
Q1 | $1.21M | Buy |
5,994
+39
| +0.7% | +$7.87K | 0.03% | 451 |
|
|
2022
Q4 | $1.3M | Buy |
5,955
+44
| +0.7% | +$9.59K | 0.03% | 432 |
|
|
2022
Q3 | $1.16M | Buy |
+5,911
| New | +$1.16M | 0.03% | 435 |
|